Pricing | |||||
5400 | |||||
3400 | |||||
1800 | |||||
Study Period | 2019-2030 |
Market Size (2023): | USD15Billion |
Market Size (2030): | USD25Billion |
CAGR (2023 - 2030): | 7.70% |
Fastest Growing Region | North America |
Dominating Region | Europe |
Report Features |
Details |
Base Year |
2023 |
Based Year Market Size (2023) |
USD15Billion |
Historical Period |
2019 to 2023 |
CAGR (2023 to 2030) |
7.70% |
Forecast Period |
2023 to 2030 |
Forecasted Period Market Size (2030) |
USD25Billion |
Scope of the Report |
Segmentation by Type Chemotherapy, Radiotherapy, Pain Management, Nutritional Supplements, Segmentation by Application Palliative Care, Pain Management, Nutritional Support, Psychological Support, Home Healthcare, Sales Channel |
Regions Covered |
|
Companies Covered |
Amgen, Celgene, Pfizer, Merck, Roche, Novartis, GSK, Teva Pharmaceutical Industries, AstraZeneca, Gilead Sciences, Bristol-Myers Squibb, Sanofi, AbbVie |
Customization Scope |
15% Free Customization (For EG) |
Delivery Format |
PDF and Excel through Email |